Hyperglycemia in a Hospital Setting
Pharmacists play a key role treating patients who are admitted to the hospital with hyperglycemia. Clinicians should be up to date on the management of inpatient hyperglycemia, regardless of the etiology. This session focuses on literature and guidelines that provide insight into managing and monitoring hyperglycemia in admitted patients. The program will utilize an evidence-based approach to discuss various strategies for optimizing pharmacotherapy and mitigating potential complications.
At the completion of this activity, the participant should be able to:
- Assess the level of hyperglycemia that requires treatment in hospitalized patients
- Determine which non-insulin antidiabetic medications should be discontinued when admitted to the hospital
- Choose the appropriate pharmacotherapy for hyperglycemic critical and non-critical patients, and how to transition between different insulin regimens
- Explain the treatment approach when faced with a hyperglycemic crisis such as Diabetic Ketoacidosis or Hyperosmolar Hyperglycemic State
Andre Yonan, PharmD., is a current PGY-1 acute care pharmacy resident at Mount Auburn Hospital in Cambridge, Massachusetts. He received his Doctorate of Pharmacy from Massachusetts College of Pharmacy and Health Sciences.
Registration Fee: Free for MCPHS alumni, full-time staff, and for all other professionals.
Release Date: May 8, 2023
Expiration Date: May 8, 2024
ACPE UAN: 0026-0000-23-009-H01-P | Knowledge
Topic Designator: Disease State Management/Drug Therapy
Contact Hours: 1 (0.1 CEU)
Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Massachusetts College of Pharmacy and Health Sciences designates this activity for a total of 1.0 contact hour (0.1 CEUs).
To receive credit, the participant must view the entire presentation and complete the pre and post-tests, and evaluation form. Upon completion, participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.
Massachusetts College of Pharmacy and Health Sciences adheres to the ACPE Standards for Integrity and Independence in Continuing Education. It is the policy of MCPHS that the speakers and planning committee members disclose all financial relationships with ineligible companies within the last 24 months, and that relevant conflicts of interest are mitigated. Speakers will disclose any off-label/unapproved use of drugs or devices during their presentation.
Andre Yonan, PharmD, has no relevant financial relationships with ineligible companies to disclose.
Content reviewer, Dr. Hailey Choi, PharmD, holds a relevant financial relationship with the ineligible company Novo Nordisk, where she is a member of the Speaker's Bureau. The content developed does not endorse the product lines or solutions produced or offered by Novo Nordisk.
Massachusetts College of Pharmacy and Health Sciences Continuing Education staff members hold no financial relationships with ineligible companies, related to the content of this presentation.
No funding from industry provided for this event. No exhibitors will be present.